The drug manufacturing industry is a lucrative sector for investors seeking growth opportunities. With increasing demand for pharmaceutical products and advancements in medical technology, drug manufacturers are well-positioned to capitalize on rising healthcare needs. Stocks in this industry are highly influenced by factors such as regulatory approvals, patent expirations, and market competition. Investors can analyze financial performance, pipeline of new drugs, and market trends to make informed decisions when investing in drug manufacturer stocks. Overall, the drug manufacturing industry presents a promising prospect for investors looking to diversify their portfolio and tap into the booming healthcare sector.
| Symbol | Exchange | Name | MCAP | Price | Change | PE Ratio | Yield |
|---|---|---|---|---|---|---|---|
| IXHL | NASDAQ | Incannex Healthcare Inc | 0.11B | 0.31 | 0.13 | 0.00 | 0.00 |
| CRDL | NASDAQ | Cardiol Therapeutics Inc. - Class A Common Shares | 0.12B | 1.07 | 0.95 | 0.00 | 0.00 |
| CGC | NASDAQ | Canopy Growth Corporation - Common Shares | 0.44B | 1.16 | -0.86 | 0.00 | 0.00 |
| AKBA | NASDAQ | Akebia Therapeutics Inc | 0.38B | 1.42 | -2.07 | 11.34 | 0.00 |
| OGI | NASDAQ | Organigram Holdings Inc. - Common Shares | 0.20B | 1.48 | -4.52 | 11.38 | 0.00 |
| PROC | NASDAQ | Procaps Group SA | 0.18B | 1.62 | -5.27 | 0.00 | 0.00 |
| CRON | NASDAQ | Cronos Group Inc. - Common Share | 0.98B | 2.57 | 2.39 | 23.45 | 0.00 |
| TKNO | NASDAQ | Alpha Teknova Inc | 0.15B | 2.84 | -4.38 | 0.00 | 0.00 |
| AQST | NASDAQ | Aquestive Therapeutics Inc | 0.39B | 3.16 | -2.47 | 0.00 | 0.00 |
| ESPR | NASDAQ | Esperion Therapeutics Inc | 0.84B | 3.51 | 3.54 | 5.91 | 0.00 |
| ACB | NASDAQ | Aurora Cannabis Inc. - Common Shares | 0.20B | 3.59 | 3.17 | 16.67 | 0.00 |
| EVO | NASDAQ | Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share | 1.31B | 3.68 | 4.25 | 192.31 | 0.00 |
| ORGO | NASDAQ | Organogenesis Holdings Inc | 0.47B | 3.71 | -4.88 | 32.26 | 0.00 |
| IRWD | NASDAQ | Ironwood Pharmaceuticals Inc | 0.72B | 4.44 | -3.27 | 25.03 | 0.00 |
| EOLS | NASDAQ | Evolus Inc | 0.30B | 4.66 | -2.92 | 142.86 | 0.00 |
| ALVO | NASDAQ | Alvotech | 1.62B | 5.21 | -2.07 | 20.48 | 0.00 |
| SIGA | NASDAQ | SIGA Technologies Inc | 0.48B | 6.72 | -1.54 | 6.59 | 0.00 |
| TLRY | NASDAQ | Tilray Brands Inc | 0.88B | 7.59 | -3.38 | 11.29 | 0.00 |
| LFCR | NASDAQ | Lifecore Biomedical Inc | 0.32B | 8.48 | -0.36 | 40.17 | 0.00 |
| DERM | NASDAQ | Journey Medical Corp | 0.28B | 8.55 | -0.47 | 32.26 | 0.00 |
| GRFS | NASDAQ | Grifols, S.A. - American Depositary Shares | 6.27B | 9.22 | 0.33 | 14.28 | 0.02 |
| ANIK | NASDAQ | Anika Therapeutics Inc | 0.14B | 10.02 | 4.05 | 38.76 | 0.00 |
| HLN | NYSE | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | 46.71B | 10.49 | -0.67 | 24.51 | 0.02 |
| EBS | NYSE | Emergent BioSolutions Inc | 0.60B | 11.33 | 2.68 | 8.22 | 0.00 |
| VTRS | NASDAQ | Viatris Inc | 15.08B | 13.09 | 0.16 | 6.44 | 0.03 |
| RDY | NYSE | Dr. Reddy's Laboratories Ltd Common Stock | 11.69B | 14.04 | 1.63 | 19.10 | 0.01 |
| PRGO | NYSE | Perrigo Co PLC | 1.95B | 14.14 | -1.26 | 5.62 | 0.08 |
| AMRX | NASDAQ | Amneal Pharmaceuticals Inc | 4.60B | 14.63 | 0.73 | 1,482.00 | 0.00 |
| HCM | NASDAQ | HUTCHMED (China) Limited - American Depositary Shares | 2.60B | 15.10 | -0.79 | 5.57 | 0.00 |
| AMRN | NASDAQ | Amarin Corp PLC | 0.32B | 15.15 | 1.96 | 522.39 | 0.00 |
| ETON | NASDAQ | Eton Pharmaceuticals Inc | 0.41B | 15.21 | 2.71 | 14.60 | 0.00 |
| DVAX | NASDAQ | Dynavax Technologies Corp | 1.76B | 15.50 | -0.04 | 0.00 | 0.00 |
| TAK | NYSE | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 51.37B | 18.46 | 0.49 | 80.32 | 0.04 |
| PCRX | NASDAQ | Pacira BioSciences Inc | 0.84B | 20.50 | 2.05 | 45.70 | 0.00 |
| AVDL | NASDAQ | Avadel Pharmaceuticals PLC | 2.12B | 21.57 | 0.05 | 16.86 | 0.00 |
| ELAN | NYSE | Elanco Animal Health Inc | 12.72B | 25.61 | 3.15 | 359.00 | 0.00 |
| RGC | NASDAQ | Regencell Bioscience Holdings Ltd | 13.49B | 27.29 | 9.21 | 0.00 | 0.00 |
| PFE | NYSE | Pfizer Inc | 156.98B | 27.61 | 2.07 | 20.28 | 0.06 |
| AMPH | NASDAQ | Amphastar Pharmaceuticals Inc | 1.31B | 28.61 | -2.23 | 12.62 | 0.00 |
| TEVA | NYSE | Teva Pharmaceutical Industries Limited American Depositary Shares | 36.95B | 31.73 | 0.23 | 28.03 | 0.00 |
| INDV | NASDAQ | Indivior PLC - Ordinary Shares | 4.20B | 33.62 | -2.17 | 34.45 | 0.00 |
| ALKS | NASDAQ | Alkermes PLC | 5.75B | 34.84 | -0.21 | 16.57 | 0.00 |
| KNSA | NASDAQ | Kiniksa Pharmaceuticals International PLC | 3.41B | 44.98 | 0.61 | 99.36 | 0.00 |
| COLL | NASDAQ | Collegium Pharmaceutical Inc | 1.46B | 46.19 | 2.01 | 28.08 | 0.00 |
| SNY | NASDAQ | Sanofi - American Depositary Shares | 111.59B | 46.20 | 0.94 | 19.54 | 0.05 |
| SUPN | NASDAQ | Supernus Pharmaceuticals Inc | 2.77B | 48.30 | -1.55 | 32.16 | 0.00 |
| HROW | NASDAQ | Harrow Inc | 1.81B | 48.86 | 2.41 | 44.25 | 0.00 |
| NVO | NYSE | Novo Nordisk A/S Common Stock | 218.42B | 49.12 | -0.51 | 13.54 | 0.03 |
| PAHC | NASDAQ | Phibro Animal Health Corp | 2.03B | 50.00 | 21.96 | 23.16 | 0.01 |
| GSK | NYSE | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | 119.03B | 59.32 | 3.65 | 15.58 | 0.03 |
| BMY | NYSE | Bristol-Myers Squibb Co | 124.02B | 60.90 | 1.62 | 17.55 | 0.04 |
| PBH | NYSE | Prestige Consumer Healthcare Inc | 3.14B | 66.33 | 1.19 | 17.67 | 0.00 |
| LNTH | NASDAQ | Lantheus Holdings Inc | 4.45B | 67.07 | 0.59 | 28.51 | 0.00 |
| ANIP | NASDAQ | ANI Pharmaceuticals Inc | 1.82B | 80.96 | 1.35 | 47.89 | 0.00 |
| MRK | NYSE | Merck & Co Inc | 290.77B | 117.15 | -0.43 | 16.68 | 0.03 |
| ITCI | NASDAQ | Intra-Cellular Therapies Inc | 13.68B | 128.45 | -0.11 | 0.00 | 0.00 |
| ZTS | NYSE | Zoetis Inc | 54.32B | 128.67 | 0.43 | 21.04 | 0.02 |
| NBIX | NASDAQ | Neurocrine Biosciences Inc | 13.70B | 136.46 | 0.30 | 26.56 | 0.00 |
| NVS | NYSE | Novartis AG Common Stock | 294.47B | 154.32 | 0.93 | 22.81 | 0.02 |
| AZN | NASDAQ | AstraZeneca PLC - American Depositary Shares | 294.68B | 190.08 | -1.53 | 31.27 | 0.02 |
| BIIB | NASDAQ | Biogen Inc | 29.01B | 197.70 | 1.13 | 22.36 | 0.00 |
| ABBV | NYSE | AbbVie Inc | 387.09B | 219.02 | 0.88 | 96.40 | 0.03 |
| JNJ | NYSE | Johnson & Johnson | 575.10B | 238.64 | -0.57 | 22.17 | 0.02 |
| AMGN | NASDAQ | Amgen Inc | 197.38B | 366.20 | 8.16 | 25.94 | 0.03 |
| LLY | NYSE | Eli Lilly and Co | 932.79B | 1,042.20 | 1.77 | 45.32 | 0.01 |
The drug manufacturing industry is a vital part of the healthcare sector, producing medications that treat a wide range of illnesses and conditions. Investing in drug manufacturer stocks can be appealing to many investors due to the essential nature of the products these companies produce and the potential for significant returns. In this article, we'll explore the ins and outs of investing in drug manufacturers industry stocks.
There are several reasons why investing in drug manufacturer stocks can be a wise choice. These companies often have stable revenue streams, as demand for medications is generally consistent regardless of economic conditions. Additionally, many drug manufacturers have a strong track record of innovation, continuously developing new treatments and technologies.
While investing in drug manufacturer stocks can be rewarding, it also carries certain risks. The industry is highly regulated, and companies can face challenges gaining approval for new medications or navigating changing healthcare policies. Additionally, patent expirations and competition from generic drug manufacturers can impact a company's profitability.
Investing in drug manufacturer stocks can be a way to add diversity to your portfolio and potentially benefit from the healthcare sector's growth. Before investing, be sure to research individual companies thoroughly, consider the risks and rewards, and consult with a financial advisor to make informed decisions.
When investing in drug manufacturer stocks, it's essential to consider the company's track record of innovation, pipeline of products in development, regulatory challenges, competition, and market trends.
You can stay informed about developments in the drug manufacturing industry by following healthcare news outlets, attending industry conferences, monitoring company earnings reports, and consulting with financial experts who specialize in healthcare investments.
Yes, drug manufacturer stocks can be influenced by changes in healthcare policies, such as pricing regulations, reimbursement rates, and government healthcare spending. It's essential to stay informed about these policies and their potential impact on the industry.